Silvercrest Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.7M | Buy |
461,588
+395,123
| +594% | +$21.5M | 0.13% | 212 |
|
|
2026
Q1 | $4.17M | Sell |
66,465
-2,549
| -4% | -$204K | 0.03% | 447 |
|
|
2025
Q4 | $6.58M | Sell |
69,014
-728
| -1% | -$71.4K | 0.05% | 397 |
|
|
2025
Q3 | $6.81M | Buy |
69,742
+1,486
| +2% | +$154K | 0.05% | 382 |
|
|
2025
Q2 | $7.33M | Buy |
68,256
+2,635
| +4% | +$267K | 0.05% | 372 |
|
|
2025
Q1 | $6.62M | Sell |
65,621
-2,674
| -4% | -$269K | 0.05% | 362 |
|
|
2024
Q4 | $6.1M | Buy |
68,295
+4,095
| +6% | +$360K | 0.04% | 382 |
|
|
2024
Q3 | $5.38M | Buy |
64,200
+7,259
| +13% | +$572K | 0.04% | 375 |
|
|
2024
Q2 | $4.39M | Buy |
56,941
+6,133
| +12% | +$449K | 0.03% | 422 |
|
|
2024
Q1 | $3.48M | Buy |
50,808
+11,138
| +28% | +$716K | 0.02% | 441 |
|
|
2023
Q4 | $2.29M | Buy |
39,670
+32,733
| +472% | +$1.75M | 0.02% | 476 |
|
|
2023
Q3 | $366K | Hold |
6,937
| – | – | ﹤0.01% | 721 |
|
|
2023
Q2 | $375K | Sell |
6,937
-13
| -0.2% | -$679 | ﹤0.01% | 715 |
|
|
2023
Q1 | $348K | Hold |
6,950
| – | – | ﹤0.01% | 698 |
|
|
2022
Q4 | $322K | Sell |
6,950
-11
| -0.2% | -$476 | ﹤0.01% | 697 |
|
|
2022
Q3 | $270K | Sell |
6,961
-2,000
| -22% | -$80.2K | ﹤0.01% | 717 |
|
|
2022
Q2 | $334K | Sell |
8,961
-409
| -4% | -$16.6K | ﹤0.01% | 702 |
|
|
2022
Q1 | $415K | Buy |
9,370
+11
| +0.1% | +$477 | ﹤0.01% | 712 |
|
|
2021
Q4 | $398K | Sell |
9,359
-3,288
| -26% | -$138K | ﹤0.01% | 702 |
|
|
2021
Q3 | $549K | Sell |
12,647
-573
| -4% | -$25.4K | ﹤0.01% | 660 |
|
|
2021
Q2 | $565K | Buy |
13,220
+320
| +2% | +$13.5K | ﹤0.01% | 647 |
|
|
2021
Q1 | $499K | Sell |
12,900
-8,625
| -40% | -$326K | ﹤0.01% | 669 |
|
|
2020
Q4 | $774K | Sell |
21,525
-1,015
| -5% | -$36.6K | 0.01% | 571 |
|
|
2020
Q3 | $861K | Hold |
22,540
| – | – | 0.01% | 534 |
|
|
2020
Q2 | $791K | Buy |
22,540
+4,000
| +22% | +$144K | 0.01% | 543 |
|
|
2020
Q1 | $605K | Buy |
18,540
+8,300
| +81% | +$324K | 0.01% | 550 |
|
|
2019
Q4 | $463K | Hold |
10,240
| – | – | ﹤0.01% | 607 |
|
|
2019
Q3 | $417K | Buy |
10,240
+790
| +8% | +$33.5K | ﹤0.01% | 602 |
|
|
2019
Q2 | $406K | Sell |
9,450
-170
| -2% | -$6.54K | ﹤0.01% | 457 |
|
|
2019
Q1 | $369K | Hold |
9,620
| – | – | ﹤0.01% | 455 |
|
|
2018
Q4 | $340K | Hold |
9,620
| – | – | ﹤0.01% | 421 |
|
|
2018
Q3 | $370K | Sell |
9,620
-198
| -2% | -$6.92K | ﹤0.01% | 434 |
|
|
2018
Q2 | $321K | Sell |
9,818
-25
| -0.3% | -$754 | ﹤0.01% | 450 |
|
|
2018
Q1 | $269K | Hold |
9,843
| – | – | ﹤0.01% | 489 |
|
|
2017
Q4 | $244K | Sell |
9,843
-2,464
| -20% | -$68K | ﹤0.01% | 513 |
|
|
2017
Q3 | $359K | Sell |
12,307
-36
| -0.3% | -$994 | ﹤0.01% | 448 |
|
|
2017
Q2 | $342K | Buy |
12,343
+2,400
| +24% | +$63.7K | ﹤0.01% | 442 |
|
|
2017
Q1 | $247K | Sell |
9,943
-35
| -0.4% | -$851 | ﹤0.01% | 518 |
|
|
2016
Q4 | $216K | Sell |
9,978
-265
| -3% | -$5.78K | ﹤0.01% | 543 |
|
|
2016
Q3 | $244K | Buy |
10,243
+60
| +0.6% | +$1.43K | ﹤0.01% | 492 |
|
|
2016
Q2 | $238K | Sell |
10,183
-32
| -0.3% | -$692 | ﹤0.01% | 500 |
|
|
2016
Q1 | $192K | Sell |
10,215
-1,525
| -13% | -$26.8K | ﹤0.01% | 520 |
|
|
2015
Q4 | $216K | Hold |
11,740
| – | – | ﹤0.01% | 526 |
|
|
2015
Q3 | $193K | Hold |
11,740
| – | – | ﹤0.01% | 460 |
|
|
2015
Q2 | $208K | Buy |
+11,740
| New | +$210K | ﹤0.01% | 487 |
|
|
2015
Q1 | – | Sell |
-11,415
| Closed | -$151K | – | 489 |
|
|
2014
Q4 | $151K | Buy |
+11,415
| New | +$146K | ﹤0.01% | 463 |
|
|
2014
Q3 | – | Sell |
-14,765
| Closed | -$189K | – | 463 |
|
|
2014
Q2 | $189K | Buy |
+14,765
| New | +$192K | ﹤0.01% | 457 |
|
Other funds holding BSX
Silvercrest Asset Management's BSX Position: Q2 2026 in Review
Silvercrest Asset Management increased its Boston Scientific (BSX) stake by 594% in Q2 2026, buying an estimated $21.5M and bringing the position to 461,588 shares worth $19.7M. The position accounts for 0.13% of the portfolio, ranked #212.
Silvercrest Asset Management first reported a position in BSX in Q2 2014 and has held it in 47 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Silvercrest Asset Management held 461,588 shares of Boston Scientific worth $19.7M as of Q2 2026.
- Silvercrest Asset Management bought 395,123 Boston Scientific shares in Q2 2026, an estimated $21.5M.
- Boston Scientific made up 0.13% of Silvercrest Asset Management's portfolio in Q2 2026, its #212 holding.
- Silvercrest Asset Management first reported a position in Boston Scientific in Q2 2014 and has held it in 47 quarters since.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.